The study had two objectives: to demonstrate PF3944 could achieve continued weight loss when switching from weekly to monthly subcutaneous injections and maintain its efficacy while reducing the dosing frequency four-fold and to demonstrate PF3944 could switch to a four-fold equivalent monthly dose while maintaining a well-tolerated and favorable safety profile
For changes in insulin level, although the result was not statistically significant, the effect size showed that GLP-1 receptor agonists could increase insulin content in vivo, which is consistent with the pharmacological effects of the drug
If you have any questions, consult your provider for medical advice regarding your growth hormone therapy
Um, and then I also put my ex husband, I let him do a little bit of it cause he just started to get this insulin belly, total like tennis pro
How Maintenance Differs From Titration and Induction Phases The titration phase, which spans the first month to four months of treatment, involves stepping your dose up incrementally to build tolerance and identify your therapeutic window
Nh m ln da tr nn trng sng, hng ho hn